Skip to main content

Patients Support Program

At AuroCare, empathy is our foundation, excellence is our standard,
and meaningful care is the impact we deliver.

Auro-Dimethyl Fumarate

Auro-Dimethyl Fumarate is indicated for the treatment of Relapsing-Remitting Multiple Sclerosis (RRMS) in adults, to reduce the number of relapses and help delay disability progression. Canadian reference product TECFIDERA®.

Learn More

Auro-Enzalutamide

Auro-Enzalutamide is indicated for the treatment of metastatic castration-resistant prostate cancer (mCRPC) that has spread to other parts of the body  and metastatic castration-sensitive prostate cancer (mCSPC). Canadian reference product XTANDI®.

Learn More

Auro-Nintedanib

Auro-Nintedanib is indicated for the treatment of Idiopathic Pulmonary Fibrosis (IPF), Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD), and other chronic fibrosing interstitial lung diseases. Canadian reference product OFEV®.

Learn More

Auro-Pirfenidone

Auro-Pirfenidone is indicated for the treatment of Idiopathic Pulmonary Fibrosis (IPF) in adult patients. It is a generic version of the Canadian reference product ESBRIET®, providing a therapeutically equivalent treatment option.

Learn More

Auro-Tofacitinib

Auro-Tofacitinib is indicated for the management of Rheumatoid Arthritis, Psoriatic Arthritis, and Ulcerative Colitis in adult patients. It is a generic version of the Canadian reference product XELJANZ®, providing a therapeutically equivalent treatment option.

Learn More

Auro-Tofacitinib

Every conversation begins with understanding, every step reflects expertise,
and every outcome elevates patient well-being.

*Subject to provincial regulations. Co-Pay support and financial support through Auro Care™ is not available to Quebec residents.